GDTC – cytomed therapeutics limited - ordinary shares (US:NASDAQ)
Stock Stats
News
CytoMed Therapeutics Refutes Misleading Claims and Reaffirms Clinical Progress
CytoMed Therapeutics’ new year update and seeks shareholders’ feedback on proposal to improve shareholder value for their patient capital
CytoMed Therapeutics Announces Novel First-In-Human Clinical Trial Collaborations with Renowned and Prestigious Hospital Partner to Advance Its Off-The-Shelf Donor-Derived Gamma Delta T Cells Allogeneic Technology to Treat Cancers in Malaysia
CytoMed Therapeutics Completes Acquisition of T Cell Technology from UK to Treat Cancers in China and India
CytoMed Therapeutics Secures Non-Dilutive Investment for Subsidiary LongevityBank from ICH Capital and Updates on New China Strategy
Form 6-K CytoMed Therapeutics For: Jan 28
Form 6-K CytoMed Therapeutics For: Jan 13
Form 6-K CytoMed Therapeutics For: Dec 08
Form 6-K CytoMed Therapeutics For: Nov 18
Form 6-K CytoMed Therapeutics For: Nov 06
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.